Skip to content

Ardelyx ARDX Accounts Payable

Accounts Payable at other companies

Amgen logo
AmgenAMGN
$2.94B+22.0%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$593M-4.4%
XER
Xeris Biopharma Holdings, Inc.XERS
$11.47M+80.5%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$13.49M+177%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$773M+62.7%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$2.66M-36.9%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's accounts payable?
Ardelyx (ARDX) reported accounts payable of $28.2M in Q1 2026.
How has Ardelyx's accounts payable changed year-over-year?
Ardelyx's accounts payable increased by 105.5% year-over-year, from $13.72M to $28.2M.
What is the long-term trend for Ardelyx's accounts payable?
Over 5 years (2020 to 2025), Ardelyx's accounts payable has grown at a 27.9% compound annual growth rate (CAGR), from $5.63M to $19.24M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.